Vladimir Borzan
Appearances
- DateMay 9, 2023BACKGROUND: After successful induction, a subset of patients with Crohn’s disease (CD) experience a secondary loss of response (LoR) to ustekinumab (UST) maintenance therapy. Dose intensification may assist in regaining response…
Presenter
Northwestern Feinberg School of MedicineSpeakers
Icahn School of Medicine at Mount Sinai
